Position in TLRY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,388
-$5,448 QoQ
Shares Held
1,200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#122
of 235 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Concord Wealth Partners holds $46,411 across 4 Drug Manufacturers - Specialty & Generic names. TLRY ranks #3 (11.6% of the industry book) .
All Filings in TLRY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,388 | 1,200 | Shares | Sole | 2026-07-27 | |
| 2025-12-31 | $10,836 | 1,200 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $20,775 | 12,009 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,283 | 8,009 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $4,625 | 7,009 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $7,642 | 5,746 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $7,935 | 4,509 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,484 | 4,509 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $11,137 | 4,509 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $10,370 | 4,509 | Shares | Sole | 2024-04-30 | |
| 2023-09-30 | $10,776 | 4,509 | Shares | Sole | 2024-04-30 | |
| 2023-06-30 | $7,034 | 4,509 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $11,407 | 4,509 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $12,129 | 4,509 | Shares | Sole | 2023-01-30 | |
| 2022-06-30 | $14,068 | 4,509 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $31,149 | 4,009 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $29,652 | 4,218 | Shares | Sole | 2022-01-21 | |
| 2021-06-30 | $162 | 9 | Shares | Sole | 2021-07-29 | |
| No filing history on record for this holder in this stock. | ||||||